AZD1222-induced mucosal immune responses are influenced by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection. Aksyuk et al.

Name: AZD1222-induced mucosal immune responses are influenced by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection. Aksyuk et al.
Creator: Anastasia Aksyuk
Published: 2022-12-06T17:43:53.185Z
Keywords: Vaccination, COVID-19

Aksyuk, Anastasia; Bansal, Himanshu; Wilkins, Deidre; Stanley, Ann Marie; Sproule, Stephanie; Maaske, Jill; Sanikommu, Satya; Hartman, William; Sobieszczyk, Magdalena; Falsey, Ann; Kelly, Elizabeth

doi:10.17632/3nxrpnf7m3.1

AZD1222-induced mucosal immune responses are influenced by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection. Aksyuk et al.

Published: 6 December 2022| Version 1 | DOI: 10.17632/3nxrpnf7m3.1

Contributors:

Anastasia Aksyuk, Himanshu Bansal, Deidre Wilkins, Ann Marie Stanley, Stephanie Sproule, Jill Maaske, Satya Sanikommu, William Hartman, Magdalena Sobieszczyk, Ann Falsey, Elizabeth Kelly

Description

Supplemental Table 3. Summary of GMTs, GMFRs, and seroresponse rates of anti-SARS-CoV-2 spike IgG and IgA as measured by MSD serology assay. Related to Figures 1–2.

Files

Funders

US Government
Grant ID: W15QKN-20-9-1003
Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority
Grant ID: W15QKN-21-9-1003
Infectious Diseases Clinical Research Consortium through the National Institute of Allergy and Infectious Diseases,
Grant ID: UM1 AI 148684, UM1 AI 148450, UM1 AI 148372, and UM1 AI 148574

AZD1222-induced mucosal immune responses are influenced by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection. Aksyuk et al.

Description

Files

Categories

Funders

Licence